Intelligent Agent-Delivering Neural Probe Systems
Legal Citation
Summary of the Inventive Concept
This inventive concept integrates advanced technologies like AI, IoT, blockchain, and novel biomaterials with agent-delivering neural probes to create a more powerful system for neural stimulation and treatment.
Background and Problem Solved
Known neural probes have limitations in terms of damage to brain tissue, limited treatment agent delivery, and inadequate data tracking. This inventive concept addresses these limitations by incorporating synergistic technologies to enhance the functionality and efficacy of agent-delivering neural probes.
Detailed Description of the Inventive Concept
The inventive concept comprises a neural probe device with integrated AI-powered agent delivery systems, IoT-enabled sensors for real-time brain activity monitoring, blockchain-based secure data storage, and novel biomaterial coatings for enhanced agent delivery. The AI-powered system optimizes agent delivery based on patient-specific data, while the IoT-enabled sensor provides real-time feedback for personalized therapy. The blockchain-based data storage system ensures secure and transparent tracking of agent delivery and stimulation data.
Novelty and Inventive Step
The inventive concept's novelty lies in the synergistic integration of AI, IoT, blockchain, and novel biomaterials with agent-delivering neural probes, providing a more powerful system for neural stimulation and treatment. The inventive step is the combination of these distinct technologies to create a system that is more than the sum of its parts.
Alternative Embodiments and Variations
Alternative embodiments could include the use of different AI algorithms, IoT protocols, or blockchain platforms. Variations could include the integration of additional technologies, such as machine learning-based recommendation engines or cloud-based data analytics platforms.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the fields of neurology, neuroscience, and medical technology, with potential applications in treating neurological disorders, such as epilepsy, Parkinson's disease, and chronic pain.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Neurological medical devices, specifically neural probe technologies with agent delivery systems, requiring advanced knowledge in biomedical engineering, neuroscience, materials science, and electronic systems integration
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or neurotechnology researcher with advanced degrees, expertise in neural interface design, familiarity with biomaterials, embedded systems, and interdisciplinary medical device development
Obviousness Rationale
A PHOSITA would recognize that integrating advanced digital technologies like AI, IoT, and blockchain with existing neural probe agent delivery systems represents a predictable technological evolution. The source patent's foundational neural probe design provides a clear technological framework that naturally invites computational and data management enhancements. The proposed variations represent logical extensions of existing neural interface technologies using well-established interdisciplinary engineering approaches.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,326 |
|---|---|
| Title | Agent-delivering neural probe devices and related systems and methods |
| Assignee(s) | NeuroOne Medical Technologies Corporation |